Table 2. Disease incidence rate between two biennial health screening periods

	Prehypertension group			Prediabetes group
Outcome	Men	Women	P for gender difference	Men	Women	P for gender difference
	Incidence rate (per 10,000 PY), [95% CI]	Incidence rate (per 10,000 PY), [95% CI]		Incidence rate (per 10,000 PY), [95% CI]	Incidence rate (per 10,000 PY), [95% CI]
MACE1)	62.63 [60.71–64.61]	62.05 [59.56–64.65]	0.724	87.98 [85.09–90.97]	92.78 [88.70–97.04]	0.063
Non-fatal MI	18.52 [17.50–19.60]	12.14 [11.08–13.30]	<0.001	23.13 [21.69–24.67]	19.11 [17.34–21.06]	0.001
Non-fatal stroke	44.21 [42.61–45.87]	50.31 [48.07–52.64]	<0.001	64.04 [61.59–66.58]	74.51 [70.88–78.32]	<0.001
CVD death	3.85 [3.41–4.35]	3.20 [2.69–3.82]	0.093	7.47 [6.68–8.34]	6.55 [5.56–7.71]	0.195
All-cause death	47.13 [45.49–48.82]	24.27 [22.76–25.89]	<0.001	66.73 [64.26–69.29]	41.38 [38.75–44.20]	<0.001

MACE, major adverse cardiovascular events; MI, myocardial infarction; CVD, cardiovascular disease.
MACE was defined as a composite of non-fatal MI, non-fatal stroke, and CVD death.